Plant-based therapeutics for chronic obstructive pulmonary diseases: Nanoformulation strategies to overcome delivery challenges
Chronic obstructive pulmonary disease (COPD) is a widespread global health problem
marked by increasing airflow limitation and chronic airway inflammation. Conventional …
marked by increasing airflow limitation and chronic airway inflammation. Conventional …
The impact of smoking on bronchiectasis and its comorbidities
D de la Rosa-Carrillo, JI de Granda-Orive… - Expert Review of …, 2024 - Taylor & Francis
Introduction Bronchiectasis, characterized by irreversible bronchial dilatation, is a growing
global health concern with significant morbidity. This review delves into the intricate …
global health concern with significant morbidity. This review delves into the intricate …
Risk of pharmacological treatment of anxiety and depression after admission for acute exacerbation of chronic obstructive pulmonary disease
JH Karlsen, PA Jacobsen, K Kragholm… - Respiratory …, 2024 - Elsevier
Background Anxiety and depression are very common in patients with COPD and may lead
to lower quality of life and higher risk of exacerbations and mortality. This study aimed to …
to lower quality of life and higher risk of exacerbations and mortality. This study aimed to …
[HTML][HTML] Mucins 3A and 3B Are Expressed in the Epithelium of Human Large Airway
H Merikallio, T Pincikova, I Kotortsi, R Karimi… - International Journal of …, 2023 - mdpi.com
Aberrant mucus secretion is a hallmark of chronic obstructive pulmonary disease (COPD).
Expression of the membrane-tethered mucins 3A and 3B (MUC3A, MUC3B) in human lung …
Expression of the membrane-tethered mucins 3A and 3B (MUC3A, MUC3B) in human lung …
New Therapies in Outpatient Pulmonary Medicine
L Granados, M John, JD Edelman - Medical Clinics, 2024 - medical.theclinics.com
Asthma is characterized by inflammation of airways and bronchial hyperresponsiveness that
leads to variable airflow obstruction. 1–3 It is a heterogeneous disease that is diagnosed …
leads to variable airflow obstruction. 1–3 It is a heterogeneous disease that is diagnosed …
The impact of illness perception on medication adherence to inhaler therapy in elderly individuals with COPD
Y Liu, Y Wang, X Peng, H Xie - Respiratory Care, 2024 - rc.rcjournal.com
Background: Medication adherence to inhaler therapy is pivotal for optimizing the
management of Chronic Obstructive Pulmonary Disease (COPD). Individuals with COPD …
management of Chronic Obstructive Pulmonary Disease (COPD). Individuals with COPD …
Association between impairment of lung function and risk of anxiety and depression in patients with chronic obstructive pulmonary disease-A systematic review
JH Karlsen, KH Jørgensen, UM Weinreich - 2024 - researchsquare.com
Background: This systematic review aims to evaluate the association between impairment of
pulmonary function, anxiety and depression in patients with chronic obstructive pulmonary …
pulmonary function, anxiety and depression in patients with chronic obstructive pulmonary …
[HTML][HTML] Terapia respiratoria en el paciente con enfermedad pulmonar
LAB Idrovo, KEC Vega, ZCT Arias, AKM Tinoco… - Medicina, 2024 - revistamedica.com
La terapia respiratoria desempeña un papel crucial en el tratamiento de enfermedades
pulmonares, aliviando síntomas, mejorando la función pulmonar y elevando la calidad de …
pulmonares, aliviando síntomas, mejorando la función pulmonar y elevando la calidad de …
Taxa de mortalidade durante episódios de exacerbação da Doença Pulmonar Obstrutiva Crônica (DPOC) em indivíduos idosos hospitalizados em uma instituição …
BP Ferreira, JH Genske, J Abramovecht… - Research, Society and …, 2024 - rsdjournal.org
Acute exacerbations (AECOPD) of COPD negatively impact health status, hospitalization
rates, disease progression and health system costs, and other acute events can mimic or …
rates, disease progression and health system costs, and other acute events can mimic or …
Risk of Anxiety and Depression after Admission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease
J Hermann Karlsen, PA Jacobsen, K Kragholm… - Peter Ascanius and … - papers.ssrn.com
Background: Anxiety and depression are very common in patients with COPD, and may lead
to lower quality of life and higher risk of exacerbations and mortality. Though, COPD is also …
to lower quality of life and higher risk of exacerbations and mortality. Though, COPD is also …